Skip to main content

Table 1 Baseline Characteristics of patients with Middle East Respiratory Syndrome (MERS) and patients with Non-MERS Severe Acute Respiratory Infection (SARI) at the time of diagnosis

From: Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)

Characteristic

MERS N = 78 (%)

Non-MERS SARI N = 57 (%)

p-value

Age-years (Mean ± SD)

(44.99 ± 12.95)

(50.04 ± 13.64)

0.31

Male gender

56 (71.8%)

34 (59.6%)

0.14

Nationality-Saudi

56 (71.8%)

34 (59.6%)

0.14

ICU admission

36 (46.2%)

32 (57.1%)

0.20

Mechanically ventilated

26 (33.3%)c

26 (45.6%)

0.10

Health care worker

20 (25.6%)

2 (3.5%)

< 0.01

Presence of comorbidity (one or more)

45 (63.4%)

44 (91.7%)

< 0.01

Comorbidities

 Diabetes

29 (37.2%)

28 (50.9%)

0.12

 Hypertension

29 (37.2%)

29 (51.8%)

0.09

 Respiratory disease

2 (2.6%)

0

0.33

 Cardiovascular disease

10 (12.8%)

19 (33.9%)

< 0.01

 Neurological disease

4 (5.1%)

12 (21.4%)

< 0.01

 Renal disease

9 (11.5%)

15 (26.8%)

0.02

  Hemodialysis

3 (3.9%)

3 (5.4%)

0.70

 Chronic liver disease

0

7 (12.5%)

< 0.01

Immunocompromiseda

6 (7.7%)

20 (35.7%)

< 0.01

Current smoker or history of smoking

26 (33.3%)

11 (19.6%)

0.08

Time to interview after illness –month (Mean ± SD)

(13.79 ± 3.43)

(25.32 ± 7.54)

< 0.01

Returned to original work at the time of interview

44 (88%)b

17 (73.9%)

0.17

  1. aImmunocompromised patients were defined as follows: (Use of systemic corticosteroids or immunosuppressive medication, preexisting organ transplantation and active cancer)
  2. bSubjects who were originally not working were excluded in the analysis
  3. cPercentage from total patients with MERS (78) and Non-MERS SARI (57)